Sodium Chromate 51

id: aa96adc4-6c5f-4863-9033-3bc5d07803b4
displayName: SPL UNCLASSIFIED SECTION
FDA Article Code: 42229-5

Per your order, we have compounded Chromium 51 as a sterile intravenous injectable dispensed as 1 mL in a 5 mL vial. The characteristics of this preparation are described below

DESCRIPTION

id: abe71126-a1f9-430a-92e2-3a79a950d78a
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3

AnazaoHealth’s compounded Cr-51 vial is a sterile, non-pyrogenic diagnostic radiopharmaceutical that consists up to 1 mCi of Cr-51 (precalibrated) in a volume up to 5 mL normal saline and 6 mg/mL benzyl alcohol.

INDICATIONS AND USAGE

id: aee5a8f7-d6e6-47c9-8a8a-be3091ba8459
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9

Cr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss

CONTRAINDICATIONS

id: a43a6c3e-1eb8-4f41-a1e5-e44b5b118692
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3

There are no known contraindications for this preparation

DOSAGE AND ADMINISTRATION

id: a2a4b15d-c8c6-4b1c-a912-a93763a4ff5c
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7

The suggested dose range in the average patient (70kg) is:
Determination of red blood cell volume or mass-0.37 to 1.11 megabecquerels (10 to 30 microcuries).
Study of red blood cell survival time-5.55 megabecquerels (150 microcuries).
Evaluation of blood loss-7.40 megabecquerels (200 microcuries)

id: a18265a1-457f-46ce-901c-7473a1818543
displayName: SPL UNCLASSIFIED SECTION
FDA Article Code: 42229-5

Figure 1

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

id: afd9970d-0add-489e-9f56-7ad41f0e3b61
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4

Figure 2